Home › Cholesterol › Virginia › Richmond
Cholesterol clinical trials in Richmond, VA
4 studies for Cholesterol are looking for participants at sites in and around Richmond (within about 30 miles). Open a study to see who can join and how to contact the study team.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Chippenham Hospital, Richmond
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
RecruitingPhase 3
- Research Site, Richmond
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
RecruitingPhase 2
- Dominion Medical Associates, Richmond
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
RecruitingPhase 3
- Virginia Commonwealth University, Richmond
About Cholesterol
Your body needs some cholesterol, but too much can raise your risk of heart disease. Know the types (HDL and LDL), and how to lower high cholesterol.
More about Cholesterol on MedlinePlus
Cholesterol trials in other cities
- Washington, DC6 studies
- Hialeah, FL5 studies
- Jacksonville, FL4 studies
- Deltona, FL4 studies
- Clearwater, FL4 studies
- Durham, NC4 studies
- Dallas, TX3 studies
- Winston-Salem, NC3 studies
- Chicago, IL3 studies
- Houston, TX3 studies
- New York City, NY3 studies
- Alexandria, VA3 studies
Other studies in Richmond
- Breast Cancer26 studies
- Non-Small Cell Lung Cancer25 studies
- Prostate Cancer18 studies
- Heart Failure16 studies
- Lung Cancer14 studies
- Colorectal Cancer13 studies
- Cardiovascular Disease13 studies
- Metastatic Cancer12 studies
- Steatotic Liver Disease12 studies
- Acute Myeloid Leukemia12 studies
- Head and Neck Squamous Cell Carcinoma12 studies
- Cancer (all types)11 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.